897 related articles for article (PubMed ID: 15573184)
21. Inability of a monoclonal anti-light chain antibody to detect clonal plasma cells in a patient with multiple myeloma by multicolor flow cytometry.
van Velzen JF; van den Blink D; Bloem AC
Cytometry B Clin Cytom; 2013; 84(1):30-2. PubMed ID: 23019187
[TBL] [Abstract][Full Text] [Related]
22. A subpopulation of malignant CD34+CD138+B7-H1+ plasma cells is present in multiple myeloma patients.
Kuranda K; Berthon C; Dupont C; Wolowiec D; Leleu X; Polakowska R; Jouy N; Quesnel B
Exp Hematol; 2010 Feb; 38(2):124-31. PubMed ID: 19948206
[TBL] [Abstract][Full Text] [Related]
23. Detection of myeloma cells in the peripheral blood by flow cytometry.
Witzig TE; Kimlinger TK; Ahmann GJ; Katzmann JA; Greipp PR
Cytometry; 1996 Jun; 26(2):113-20. PubMed ID: 8817086
[TBL] [Abstract][Full Text] [Related]
24. Extranodal marginal zone B cell lymphomas of the uvea: an analysis of 13 cases.
Coupland SE; Foss HD; Hidayat AA; Cockerham GC; Hummel M; Stein H
J Pathol; 2002 Jul; 197(3):333-40. PubMed ID: 12115879
[TBL] [Abstract][Full Text] [Related]
25. Antigenic transformation in plasma cell dyscrasia.
Cruse JM; Lewis RE; Webb RN; Sanders CM; Tillman BF; Beason K; Lam J; Koehler J
Exp Mol Pathol; 2006 Oct; 81(2):157-61. PubMed ID: 16908019
[TBL] [Abstract][Full Text] [Related]
26. The sensitivity of CD138 immunostaining of bone marrow trephine specimens for quantifying marrow involvement in MGUS and myeloma, including samples with a low percentage of plasma cells.
Ng AP; Wei A; Bhurani D; Chapple P; Feleppa F; Juneja S
Haematologica; 2006 Jul; 91(7):972-5. PubMed ID: 16818287
[TBL] [Abstract][Full Text] [Related]
27. Immunophenotypic analysis of CD19+ precursors in normal human adult bone marrow: implications for minimal residual disease detection.
Ciudad J; Orfao A; Vidriales B; Macedo A; Martínez A; González M; López-Berges MC; Valverde B; San Miguel JF
Haematologica; 1998 Dec; 83(12):1069-75. PubMed ID: 9949623
[TBL] [Abstract][Full Text] [Related]
28. Detecting CD56+/NB84+/CD45- immunophenotype in the bone marrow of patients with metastatic neuroblastoma using flow cytometry.
Bozzi F; Gambirasio F; Luksch R; Collini P; Brando B; Fossati-Bellani F
Anticancer Res; 2006; 26(5A):3281-7. PubMed ID: 17094441
[TBL] [Abstract][Full Text] [Related]
29. Soluble urokinase-type plasminogen activator receptor (suPAR) as an independent factor predicting worse prognosis and extra-bone marrow involvement in multiple myeloma patients.
Rigolin GM; Tieghi A; Ciccone M; Bragotti LZ; Cavazzini F; Della Porta M; Castagnari B; Carroccia R; Guerra G; Cuneo A; Castoldi G
Br J Haematol; 2003 Mar; 120(6):953-9. PubMed ID: 12648064
[TBL] [Abstract][Full Text] [Related]
30. Detection of residual neuroblastoma cells in bone marrow: comparison of flow cytometry with immunocytochemistry.
Swerts K; De Moerloose B; Dhooge C; Brichard B; Benoit Y; Laureys G; Philippé J
Cytometry B Clin Cytom; 2004 Sep; 61(1):9-19. PubMed ID: 15351977
[TBL] [Abstract][Full Text] [Related]
31. Flow cytometric immunophenotyping and minimal residual disease analysis in multiple myeloma.
Gupta R; Bhaskar A; Kumar L; Sharma A; Jain P
Am J Clin Pathol; 2009 Nov; 132(5):728-32. PubMed ID: 19846814
[TBL] [Abstract][Full Text] [Related]
32. Six color flow cytometry detects plasma cells expressing aberrant immunophenotype in bone marrow of healthy donors.
Peceliunas V; Janiulioniene A; Matuzeviciene R; Griskevicius L
Cytometry B Clin Cytom; 2011 Sep; 80(5):318-23. PubMed ID: 21634008
[TBL] [Abstract][Full Text] [Related]
33. Utility of CD56 immunohistochemical studies in follow-up of plasma cell myeloma.
Harrington AM; Hari P; Kroft SH
Am J Clin Pathol; 2009 Jul; 132(1):60-6. PubMed ID: 19864234
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of the kinetics of the bone marrow tumor load in the course of sequential high-dose therapy assessed by quantitative PCR as a predictive parameter in patients with multiple myeloma.
Cremer FW; Ehrbrecht E; Kiel K; Benner A; Hegenbart U; Ho AD; Goldschmidt H; Moos M
Bone Marrow Transplant; 2000 Oct; 26(8):851-8. PubMed ID: 11081384
[TBL] [Abstract][Full Text] [Related]
35. A novel multiparametric approach for analysis of cytoplasmic immunoglobulin light chains by flow cytometry.
Chang CC; Schur BC; Kampalath B; Lindholm P; Becker CG; Vesole DH
Mod Pathol; 2001 Oct; 14(10):1015-21. PubMed ID: 11598172
[TBL] [Abstract][Full Text] [Related]
36. The phenotypic plasticity of myeloma plasma cells as expressed by dedifferentiation into an immature, resilient, and apoptosis-resistant phenotype.
Yaccoby S
Clin Cancer Res; 2005 Nov; 11(21):7599-606. PubMed ID: 16278377
[TBL] [Abstract][Full Text] [Related]
37. Immunophenotypic characterization of plasma cells from monoclonal gammopathy of undetermined significance patients. Implications for the differential diagnosis between MGUS and multiple myeloma.
Ocqueteau M; Orfao A; Almeida J; Bladé J; González M; García-Sanz R; López-Berges C; Moro MJ; Hernández J; Escribano L; Caballero D; Rozman M; San Miguel JF
Am J Pathol; 1998 Jun; 152(6):1655-65. PubMed ID: 9626070
[TBL] [Abstract][Full Text] [Related]
38. Diverse niches within multiple myeloma bone marrow aspirates affect plasma cell enumeration.
Nadav L; Katz BZ; Baron S; Yossipov L; Polliack A; Deutsch V; Geiger B; Naparstek E
Br J Haematol; 2006 Jun; 133(5):530-2. PubMed ID: 16681641
[TBL] [Abstract][Full Text] [Related]
39. F-18 FDG uptake of bone marrow on PET/CT scan: it's correlation with CD38/CD138 expressing myeloma cells in bone marrow of patients with multiple myeloma.
Ak I; Gulbas Z
Ann Hematol; 2011 Jan; 90(1):81-7. PubMed ID: 20690019
[TBL] [Abstract][Full Text] [Related]
40. Mantle cell lymphoma with flow cytometric evidence of clonal plasmacytic differentiation: a case report.
Naushad H; Choi WW; Page CJ; Sanger WG; Weisenburger DD; Aoun P
Cytometry B Clin Cytom; 2009 May; 76(3):218-24. PubMed ID: 19061249
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
